Articles tagged ‘’

A new formal diagnostic approach to short QT syndrome (SQTS) will improve its clinical understanding, and the ability of clinicians to evaluate potentially at-risk family members, according to a study published recently in the Journal of the American College of Cardiology.¹

Dabigatran etexilate has recently been recommended for approval in EU member states by the Committee for Medicinal Products for Human Use (CHMP), for the prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (AF).

Treatment with ticagrelor rather than clopidogrel increases the danger of ventricular pauses in patients with acute coronary syndromes (ACS), according to a study published recently in the Journal of the American College of Cardiology.¹

Thrombotic tendencies stimulated by winter cold could explain the increased CV morbidity and mortality observed during the same period, and may be prevented by prescribing antithrombotic therapies to elderly patients, according to UK researchers. The study was presented at EuroPRevent 2011 in Geneva.

The incidence and definition of sudden cardiac death (SCD) and sudden cardiac arrest (SCA) in the United States are poorly understood, requiring a standardised definition of both and ongoing research efforts to examine cases more broadly across communities, say the authors of a report¹ published recently in the Journal of the American College of Cardiology.

Pericardial fat is associated with the presence of atrial fibrillation (AF), its severity, and poorer outcomes after ablation, independently of more systemic measures of adiposity, according to a study published recently in the Journal of the American College of Cardiology¹.